Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

The robotic surgery leader is enjoying a rebound in demand.

Why Intuitive Surgical Stock Surged Today

Edwards Lifesciences

Edwards Lifesciences Corp. (NYSE:EW) and Intuitive Surgical Inc. (NASDAQ:ISRG) are on the Wall Street radar this week.

Edwards Lifesciences and Intuitive Surgical: Right Place, Right Time and Wide Moats

Shares of Intuitive Surgical jumped as much as 9.8% on Wednesday to a record high of $891.15 after the robotic surgery company crushed first quarter earnings.  The stock movement pushed Intuitive Surgical's market capitalization past $100 billion for the first time ever.

Intuitive Surgical jumps past $100 billion market value as 1st-quarter earnings report trounces even the most bullish forecasts (ISRG)

Intuitive Surgical Inc (NASDAQ: ISRG) shares have gained momentum as the surgical-robotics equipment company reported Q1 results well above Wall Street estimates.  Revenue in the first quarter reached $1.29 billion, reflecting an 18% Y/Y increase.

Intuitive Surgical Stock Is Trading Higher On Earnings Beat, As Easing Of COVID-19 Concerns Boosted Topline And Bottomline Growth

Etsy

Zoom Video

The game's not over. Let's go over some stocks where business is booming.

3 Top Stocks That Keep Getting Better

Intuitive Surgical on Tuesday reported earnings of $3.52 per share on $1.29 billion in sales for the first quarter ended March 31. In response, shares of the robotic surgery giant popped.

Intuitive Surgical Reclaims Breakout After Crushing Quarterly Earnings

Intuitive Surgical stock rose as investors digested the robotic-assisted surgery firm's better-than-expected financial results, and after two analyst upgrades.

Intuitive Surgical Stock Climbs on Strong Earnings Beat and Analyst Upgrades

The easing of COVID-19 concerns is boosting the robotic surgical systems leader's fortunes.

Here's Why Investors Loved Intuitive Surgical's Q1 Results

Anthem

Chipotle

Netflix

Verizon

Some of the stocks that may grab investor focus today are: Wall Street expects Verizon Communications Inc. (NYSE: VZ) to report quarterly earnings at $1.29 per share on revenue of $32.46 billion before the opening bell. Verizon shares fell 0.2% to $58.29 in pre-market trading.

5 Stocks To Watch For April 21, 2021

Intuitive Surgical, Inc.'s (ISRG) CEO Gary Guthart on Q1 2021 Results - Earnings Call Transcript

Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 34.87% and 16.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates

Intuitive Surgical Inc. ISRG shares rose in the extended session Tuesday after the surgical-robotics equipment company's quarterly results topped Wall Street estimates. Intuitive Surgical shares rose 3.4% after hours, following a 0.1% decline in the regular session to close at $811.11.

Intuitive Surgical stock rises on earnings beat

Shares of Intuitive Surgical (NASDAQ:ISRG) moved higher after the company reported Q1 results. Quarterly Results Earnings per share rose 30.86% year over year to $3.52, which beat the estimate of $2.63.

Recap: Intuitive Surgical Q1 Earnings

Earnings Preview: What To Expect From Intuitive Surgical On Tuesday

On Tuesday, April 20, Intuitive Surgical (NASDAQ:ISRG) will release its latest earnings report. Benzinga's outlook for Intuitive Surgical is included in the following report.

Preview: Intuitive Surgical's Earnings

Here's what you need to separate the most important signals from the rest of the noise.

3 Things to Look For When Intuitive Surgical Reports Q1 2021 Earnings

Advanced Micro Devices

Shopify

These stocks can make patient investors tons of money over the next 10 years.

3 Game-Changing Stocks to Buy and Hold for the Next Decade

You can just sit back and watch these top stocks grow.

Got $1,000? 2 of Today's Hot Stocks You Can Buy and Hold for a Lifetime

Silvergate Capital Corp

Do your stocks have moats protecting their businesses? Here are three stocks with powerful advantages that keep competitors at bay.

These 3 Stocks Will Make You Rethink Your Portfolio

Disney

There is still a lot more room for these stocks to rise once concerns relating to COVID-19 subside.

2 Growth Stocks to Buy Before the Pandemic Ends

Despite its challenges, the opportunity ahead could produce huge gains for shareholders over the long term.

In Asia, Intuitive Surgical's Growth Story Is Just Beginning

Pinterest

Trupanion

Visa

These great companies are your ticket to financial independence.

5 Surefire Stocks That Can Give You Financial Freedom

Amarin Corporation Plc

Amarin and Accelerate Diagnostics are healthcare companies with significant upside.

2 Great Stocks Under $10 per Share

Brookfield Asset Management

PayPal

No fooling. These stocks should be winners.

3 Top Stocks That Will Make You Richer in April (and Beyond!)

Illumina

Teladoc

From genomics to virtual care, these stocks should be huge long-term winners.

News for Intuitive Surgical Stock (ISRG)